{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:20:15Z","timestamp":1787066415514,"version":"build-2736575974"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Programmed cell death (PCD) plays a complex and critical role in the progression of colon adenocarcinoma (COAD). Elucidating PCD-related characteristics is expected to provide new insights for tumor subtyping, prognosis assessment, and personalized therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study integrated multi-omics data from COAD and employed 10 clustering algorithms for molecular subtyping. Based on PCD-related genes, a Programmed cell death signature (PCDS) predictive model was constructed using 113 machine learning algorithms. The focus then shifted to the core gene of the model, TERT. Single-cell and spatial transcriptomic data were incorporated to decipher its cellular localization and regulatory pathways. Finally, the function of TERT was validated through\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We categorized COAD into 5 molecular subtypes with distinct prognostic differences. Subsequently, we successfully developed an 18-gene PCDS. This model effectively predicted patient risk and overall survival in both the training set and multiple independent validation cohorts. The PCDS was closely associated with the tumor microenvironment, mutation burden, and response to immunotherapy. Single-cell and spatial transcriptomic analyses revealed that the core gene, TERT, was specifically highly expressed in malignant epithelial cells.\n                      <jats:italic>In vitro<\/jats:italic>\n                      experiments confirmed that knocking down TERT significantly inhibited the proliferation, migration, invasion, and clonogenic formation abilities of COAD cells. Mechanistically, TERT may inhibit apoptosis, regulate the cell cycle, and promote proliferation potentially through the E2F, G2\/M checkpoint, and MYC signaling pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study defines novel molecular subtypes of COAD through multi-omics clustering analysis and develops a robust PCD-related prognostic signature. Furthermore, it reveals the significant value of TERT as a potential therapeutic target in COAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1736554","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:47:11Z","timestamp":1781156831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular subtyping and prognostic modeling of colon adenocarcinoma based on programmed cell death features: a multi-omics and machine learning study"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiadiye","family":"Tuerhong","sequence":"first","affiliation":[{"name":"Department of Digestive Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirixiati","family":"Aihaiti","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5858\/2008-132-1600-CCSIIP","article-title":"Colorectal carcinoma: Selected issues in pathologic examination and staging and determination of prognostic factors","volume":"132","author":"Kay Washington","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.14670\/HH-11-633","article-title":"Histological grading in colorectal cancer: New insights and perspectives","volume":"30","year":"2015","journal-title":"Histol Histopathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: A review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-2024-861","article-title":"Identification of prognostic biomarkers in colorectal cancer through multi-omics profiling of programmed cell death pathways","volume":"16","author":"Qiao","year":"2025","journal-title":"J Gastrointest Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00912-8","article-title":"Omics-based molecular classifications empowering in precision oncology","volume":"47","author":"Zhou","year":"2024","journal-title":"Cell Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209505","article-title":"Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis","volume":"25","author":"Wendt","year":"2006","journal-title":"Oncogene"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-024-00560-8","article-title":"Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: Implications for targeted therapy","volume":"18","author":"Taha","year":"2025","journal-title":"Epigenet Chromatin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-03928-y","article-title":"AGE-RAGE synergy influences programmed cell death signaling to promote cancer","volume":"476","author":"Waghela","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"B11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.arr.2015.04.002","article-title":"Programmed cell death in aging","volume":"23","author":"Tower","year":"2015","journal-title":"Ageing Res Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106936","article-title":"Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery","volume":"107","author":"Zou","year":"2022","journal-title":"Int J Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2014.06.009","article-title":"Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury","volume":"261","author":"Donega","year":"2014","journal-title":"Exp Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0326-4","article-title":"Cell death in the gut epithelium and implications for chronic inflammation","volume":"17","author":"Patankar","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discov"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-022-01260-0","article-title":"Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: A revisited perspective from molecular mechanisms to targeted therapies","volume":"15","author":"Liao","year":"2022","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: An R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.709022","article-title":"Identification of the role and clinical prognostic value of target genes of m6A RNA methylation regulators in glioma","volume":"9","author":"Cong","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12920-022-01392-9","article-title":"Identification of the miRNA-mRNA regulatory network associated with radiosensitivity in esophageal cancer based on integrative analysis of the TCGA and GEO data","volume":"15","author":"Chen","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3900","article-title":"A novel five\u2010gene signature predicts overall survival of patients with hepatocellular carcinoma","volume":"10","author":"Wang","year":"2021","journal-title":"Cancer Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12935-021-01939-3","article-title":"Identification of an immune-related signature indicating the dedifferentiation of thyroid cells","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.565206","article-title":"Identification and validation of two lung adenocarcinoma-development characteristic gene sets for diagnosing lung adenocarcinoma and predicting prognosis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12064-012-0162-3","article-title":"Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples","volume":"131","author":"Wagner","year":"2012","journal-title":"Theory Biosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinforma Oxf Engl"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.omtn.2020.08.030","article-title":"Characterization of the immune cell infiltration landscape in head and neck squamous cell carcinoma to aid immunotherapy","volume":"22","author":"Zhang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.723817","article-title":"Identification of immune-related subtypes and characterization of tumor microenvironment infiltration in bladder cancer","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.601","article-title":"Multi\u2010omics consensus ensemble refines the classification of muscle\u2010invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies","volume":"11","author":"Lu","year":"2021","journal-title":"Clin Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114123","article-title":"Mitogen\u2010activated protein kinase activity drives cell trajectories in colorectal cancer","volume":"13","author":"Uhlitz","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176278","article-title":"Integrative clustering of multi-level \u2018omic data based on non-negative matrix factorization algorithm","volume":"12","author":"Chalise","year":"2017","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9868.00293","article-title":"Estimating the number of clusters in a data set via the gap statistic","volume":"63","author":"Tibshirani","year":"2001","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaa1018","article-title":"MOVICS: An R package for multi-omics integration and visualization in cancer subtyping","volume":"36","author":"Lu","year":"2021","journal-title":"Bioinformatics"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.107933","article-title":"A novel PCDscore based on programmed cell death-related genes can effectively predict prognosis and therapy responses of colon adenocarcinoma","volume":"170","author":"Peng","year":"2024","journal-title":"Comput Biol Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CAD.0000000000001654","article-title":"Machine learning-based integration develops a multiple programmed cell death signature for predicting the clinical outcome and drug sensitivity in colorectal cancer","volume":"36","author":"Li","year":"2025","journal-title":"Anticancer Drugs"},{"key":"B41","doi-asserted-by":"crossref","unstructured":"Development of a machine learning-derived programmed cell death index for prognostic prediction and immune insights in colorectal cancer\n          \n          608\n          \n            \n              Li\n              J\n            \n            \n              Jiang\n              Y\n            \n            \n              Nong\n              S\n            \n            \n              Liang\n              L\n            \n            \n              Chen\n              L\n            \n            \n              Gong\n              Q\n            \n          \n          10.1007\/s12672-025-02323-7\n          Discov Oncol\n          16\n          2025","DOI":"10.1007\/s12672-025-02323-7"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4167","article-title":"A robust signature of immune\u2010related long non\u2010coding RNA to predict the prognosis of bladder cancer","volume":"10","author":"Lai","year":"2021","journal-title":"Cancer Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41698-023-00408-6","article-title":"Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations","volume":"7","author":"Chang","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/bib\/bbaa032","article-title":"Machine learning-based analysis of multi-omics data on the cloud for investigating gene regulations","volume":"22","author":"Oh","year":"2021","journal-title":"Brief Bioinform"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioteChadv.2021.107739","article-title":"Using machine learning approaches for multi-omics data analysis: A review","volume":"49","author":"Reel","year":"2021","journal-title":"Biotechnol Adv"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02826-0","article-title":"Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors","volume":"131","author":"Chowdhury","year":"2024","journal-title":"Br J Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110701","article-title":"Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling","volume":"27","author":"Leonard","year":"2024","journal-title":"iScience"},{"key":"B49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s40001-024-01805-8","article-title":"Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment","volume":"29","author":"Ma","year":"2024","journal-title":"Eur J Med Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: An intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.014","article-title":"Cell death in the origin and treatment of cancer","volume":"78","author":"Strasser","year":"2020","journal-title":"Mol Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0122","article-title":"Tumor microenvironment complexity: Emerging roles in cancer therapy","volume":"72","author":"Swartz","year":"2012","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.990419","article-title":"TOX regulates T lymphocytes differentiation and its function in tumor","volume":"14","author":"Niu","year":"2023","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112260","article-title":"TIGIT presents earlier expression dynamic than PD-1 in activated CD8+ T cells and is upregulated in non-small cell lung cancer patients","volume":"396","author":"Hu","year":"2020","journal-title":"Exp Cell Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12672-024-00924-2","article-title":"A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma","volume":"15","author":"Gu","year":"2024","journal-title":"Discov Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00574-6","article-title":"Endocytosis in cancer and cancer therapy","volume":"23","author":"Banushi","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.05.026","article-title":"Telomeres and telomerase in normal and cancer stem cells","volume":"584","author":"Shay","year":"2010","journal-title":"FEBS Lett"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkac479","article-title":"Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer","volume":"51","author":"Ak\u0131nc\u0131lar","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.chembiol.2022.09.002","article-title":"Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitization","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Chem Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-023-04120-8","article-title":"Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt\/\u03b2-catenin\/c-Myc\/SOX2 pathway in colorectal cancer","volume":"21","author":"Li","year":"2023","journal-title":"J Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1736554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:47:16Z","timestamp":1781156836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1736554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2026.1736554"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1736554","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"article-number":"1736554"}}